You are here: Industry Insights > brain cancer

News List

Worldwide Brain Cancer Diagnostics Industry to 2028 - Featuring NantOmics, Biocept and Canon Medical Systems Among Others prnewswire
November 10, 2021
The "Brain Cancer Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Diagnostic Type, Cancer Type, and End User; and Geography" report has been...
Structures discovered in brain cancer patients can help fight tumors firstwordpharma
July 07, 2021
Researchers at Uppsala University have discovered lymph node-like structures close to the tumour in brain cancer patients, where immune cells can be activated to attack the tumour.
Early promise for new immunotherapy combo in brain cancer pharmatimes
April 13, 2021
A combination treatment consisting of an experimental cancer drug – ipatasertib – and Roche’s immunotherapy agent Tecentriq (atezolizumab) has demonstrated early promise in an aggressive type of brain cancer.
Novel nanocarrier enables targeted treatment of gliomas in vivo europeanpharmaceuticalreview
March 02, 2021
The new nanoparticle formulation enabled researchers to selectively target glioma cells with Dp44mT, a potent chelator and promising anti-cancer therapeutic, for the first time.
TVAX Biomedical Receives Fast Track Designation for Brain Cancer Treatment americanpharmaceuticalreview
June 15, 2020
TVAX Biomedical announced receipt of Fast Track Designation from the U.S. Food and Drug Administration (FDA) for the use of its vaccine-enhanced adoptive T cell therapy (VACT) for treatment of glioblastoma multiforme, a deadly form of brain cancer.
CNS Announces Filing of Orphan Drug Designation for Brain Cancer Drug americanpharmaceuticalreview
April 26, 2020
CNS Pharmaceuticals has filed an application with the U.S. Food and Drug Administration (FDA) to receive Orphan Drug Designation (ODD) for its lead product Berubicin.
WPD Pharmaceuticals’ Brain Cancer Drug Received Positive FDA Pre-IND Guidance americanpharmaceuticalreview
March 05, 2020
WPD Pharmaceuticals has provided an update that through its license partner, CNS Pharmaceuticals, it received positive feedback from the U.S. Food and Drug Administration (FDA) for its Pre-IND ...
Surgery May Add Years for Patients With Deadly Brain Cancer drugs
January 16, 2020
Surgical removal of the entire tumor may extend the lives of patients with a rare and deadly type of brain cancer called brainstem high-grade gliomas, a new study suggests.
Nanoparticle gene therapy drug delivery for paediatric brain cancer tested in mice europeanpharmaceuticalreview
January 13, 2020
A study has shown that PBAE nanoparticles could replace viral vectors in gene therapies and provide a safe treatment option for paediatric brain cancer patients.
Bristol-Myers Squibb's Opdivo fails 3rd straight test in tough-to-treat brain cancer fiercepharma
September 08, 2019
Bristol-Myers Squibb has once again come up empty-handed in one of the world’s deadliest and toughest-to-treat cancers.

Previous page 1 2 3 Next page